Mesenchymal stem cells (MSC) have emerged as breakthrough treatments for myocardial infarction. However, the efficacy of MSC remains unclear. The aim of the study was to evaluate treatment effect of MSC in terms of mechanical, regenerative, and clinical outcomes for patients with myocardial infarction (MI) using meta-analysis.

[pdf-embedder url=”https://www.nsorm.com/wp-content/uploads/2018/07/MSCs-in-Tx-of-Ischemic-Heart-Disease-Feb-2018.pdf” title=”MSC’s in Tx of Ischemic Heart Disease Feb 2018″]